REPORT

Mechanisms Matter: Unlocking Drug Disease Interactions with AI

Identifying Secondary Mechanisms of Action (MoAs) and Off-Target Effects 

MoAs Stats

A Strategic Advantage

By utilizing AI in R&D workflows, researchers can get an instant, holistic view of downstream signaling cascades on a cellular, molecular, and genetic level, providing key insights into secondary MoAs and potential off-target effects.

In this report, we explore: 

  • Mechanistic Understanding: Is it necessary for drug development success?
  • Applications of AI in predicting secondary MoAs and off-target drug effects. 
  • How real-life examples of AI-powered insights could help prevent herd-thinking in target selection. 
Influencer Report - Mechanisms Matter
Untitled design

See Causaly In Action

Talk to one of our experts to explore how we can support your team. 

Talk to our experts